UK markets closed

Venus Remedies Limited (VENUSREM.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
378.00+2.40 (+0.64%)
At close: 03:30PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 5.05B
Enterprise value 4.58B
Trailing P/E 17.74
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.84
Price/book (mrq)1.04
Enterprise value/revenue 0.76
Enterprise value/EBITDA 6.44

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 347.20%
S&P500 52-week change 323.76%
52-week high 3430.00
52-week low 3222.00
50-day moving average 3320.22
200-day moving average 3329.05

Share statistics

Avg vol (3-month) 362.81k
Avg vol (10-day) 3140.29k
Shares outstanding 513.37M
Implied shares outstanding 613.39M
Float 86.88M
% held by insiders 147.21%
% held by institutions 11.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.31
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 423 Sept 2013
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.74%
Operating margin (ttm)6.95%

Management effectiveness

Return on assets (ttm)3.40%
Return on equity (ttm)6.01%

Income statement

Revenue (ttm)6.01B
Revenue per share (ttm)449.87
Quarterly revenue growth (yoy)25.40%
Gross profit (ttm)N/A
EBITDA 598M
Net income avi to common (ttm)284.9M
Diluted EPS (ttm)21.32
Quarterly earnings growth (yoy)-4.90%

Balance sheet

Total cash (mrq)871.9M
Total cash per share (mrq)65.21
Total debt (mrq)413.3M
Total debt/equity (mrq)8.48%
Current ratio (mrq)4.53
Book value per share (mrq)364.62

Cash flow statement

Operating cash flow (ttm)372.8M
Levered free cash flow (ttm)107.99M